SUZHOU, China--(BUSINESS WIRE)--MabSpace Biosciences announced today that the first subject has been dosed in a Phase 1 clinical study of ... from IND clearance by FDA to first patient dosed in less than 2 months, by Dr. Papadopoulos and his team at the START clinic of San Antonio, Texas.
News
- Generation PD-L1 Antibody With a Distinct Intra-Tumor Recycling Property
- Local high school students complete Texas Bioscience Institute Middle College program
Shoemaker High School – Leilani Amituanai (University of Texas), Martin Angulo (Texas State University), Burt Cruz II (University of Mary Hardin-Baylor), Kyle Figueroa (Howard Payne University), Crystal Kinsinger (Texas Tech University), Ty'jewel Madry (University of Texas at San Antonio),…
- Independent inspectors back up UK assessment that Russia poisoned former spy
The OPCW said: "The results of analysis by the OPCW designated laboratories of environmental and biomedical samples collected by the OPCW team confirm the findings of the United Kingdom relating to the identity of the toxic chemical that was used in Salisbury and severely injured three people…
- New Lonza biotech facility in Pearland changes hands
Chicago-based Zeller Realty Group has purchased the Lonza Viral Therapy Facility, a 276,770-square-foot biotechnology facility on 11 acres at 14905 Kirby Drive in Pearland, HFF announced. HFF's Jeff Hollinden and Cameron Cureton represented the seller, Pinchal & Co., and procured the buyer…
- Real estate briefs: Equus Capital inks deals at 5300 Memorial office tower
... extension; Spain, Price, Reader & Thompson, represented by Marshall Clinkscales of Colliers, 4,097 square feet; Gulf Coast Bank & Trust, represented by Josh LaRocca of Avison Young, 3,689 square feet; and Moleculin Biotech, represented by Jane Nodskov with ICO Commercial, 2,333…